Patient-reported outcome measures for paediatric acute lower respiratory infection studies

BACKGROUND: Patient-reported outcome measures (PROMs) are recommended for capturing meaningful outcomes in clinical trials. The use of PROMs for children with acute lower respiratory infections (ALRIs) has not been systematically reported. We aimed to identify and characterise patient-reported outco...

Full description

Bibliographic Details
Published in:European Respiratory Review
Main Authors: Oakes, Daniel B., Baker, Megan J., McLeod, Charlie, Nattabi, Barbara, Blyth, Christopher C.
Format: Text
Language:English
Published: European Respiratory Society 2023
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032589/
http://www.ncbi.nlm.nih.gov/pubmed/36889787
https://doi.org/10.1183/16000617.0229-2022
id ftpubmed:oai:pubmedcentral.nih.gov:10032589
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:10032589 2023-05-15T16:16:40+02:00 Patient-reported outcome measures for paediatric acute lower respiratory infection studies Oakes, Daniel B. Baker, Megan J. McLeod, Charlie Nattabi, Barbara Blyth, Christopher C. 2023-03-08 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032589/ http://www.ncbi.nlm.nih.gov/pubmed/36889787 https://doi.org/10.1183/16000617.0229-2022 en eng European Respiratory Society http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032589/ http://www.ncbi.nlm.nih.gov/pubmed/36889787 http://dx.doi.org/10.1183/16000617.0229-2022 Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) Eur Respir Rev Reviews Text 2023 ftpubmed https://doi.org/10.1183/16000617.0229-2022 2023-03-26T02:15:55Z BACKGROUND: Patient-reported outcome measures (PROMs) are recommended for capturing meaningful outcomes in clinical trials. The use of PROMs for children with acute lower respiratory infections (ALRIs) has not been systematically reported. We aimed to identify and characterise patient-reported outcomes and PROMs used in paediatric ALRI studies and summarise their measurement properties. METHODS: Medline, Embase and Cochrane were searched (until April 2022). Studies that reported on patient-reported outcome (or measure) use or development and included subjects aged <18 years with ALRIs were included. Study, population and patient-reported outcome (or measure) characteristics were extracted. RESULTS: Of 2793 articles identified, 18 met inclusion criteria, including 12 PROMs. Two disease-specific PROMs were used in settings in which they had been validated. The Canadian Acute Respiratory Illness and Flu Scale was the most frequently used disease-specific PROM (five studies). The EuroQol-Five Dimensions-Youth system was the most frequently used generic PROM (two studies). There was considerable heterogeneity in validation methods. The outcome measures identified in this review lack validation for young children and none involve sufficient content validity for use with First Nations children. CONCLUSIONS: There is an urgent need for PROM development that considers the populations in which the burden of ALRI predominates. Text First Nations PubMed Central (PMC) European Respiratory Review 32 167 220229
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Reviews
spellingShingle Reviews
Oakes, Daniel B.
Baker, Megan J.
McLeod, Charlie
Nattabi, Barbara
Blyth, Christopher C.
Patient-reported outcome measures for paediatric acute lower respiratory infection studies
topic_facet Reviews
description BACKGROUND: Patient-reported outcome measures (PROMs) are recommended for capturing meaningful outcomes in clinical trials. The use of PROMs for children with acute lower respiratory infections (ALRIs) has not been systematically reported. We aimed to identify and characterise patient-reported outcomes and PROMs used in paediatric ALRI studies and summarise their measurement properties. METHODS: Medline, Embase and Cochrane were searched (until April 2022). Studies that reported on patient-reported outcome (or measure) use or development and included subjects aged <18 years with ALRIs were included. Study, population and patient-reported outcome (or measure) characteristics were extracted. RESULTS: Of 2793 articles identified, 18 met inclusion criteria, including 12 PROMs. Two disease-specific PROMs were used in settings in which they had been validated. The Canadian Acute Respiratory Illness and Flu Scale was the most frequently used disease-specific PROM (five studies). The EuroQol-Five Dimensions-Youth system was the most frequently used generic PROM (two studies). There was considerable heterogeneity in validation methods. The outcome measures identified in this review lack validation for young children and none involve sufficient content validity for use with First Nations children. CONCLUSIONS: There is an urgent need for PROM development that considers the populations in which the burden of ALRI predominates.
format Text
author Oakes, Daniel B.
Baker, Megan J.
McLeod, Charlie
Nattabi, Barbara
Blyth, Christopher C.
author_facet Oakes, Daniel B.
Baker, Megan J.
McLeod, Charlie
Nattabi, Barbara
Blyth, Christopher C.
author_sort Oakes, Daniel B.
title Patient-reported outcome measures for paediatric acute lower respiratory infection studies
title_short Patient-reported outcome measures for paediatric acute lower respiratory infection studies
title_full Patient-reported outcome measures for paediatric acute lower respiratory infection studies
title_fullStr Patient-reported outcome measures for paediatric acute lower respiratory infection studies
title_full_unstemmed Patient-reported outcome measures for paediatric acute lower respiratory infection studies
title_sort patient-reported outcome measures for paediatric acute lower respiratory infection studies
publisher European Respiratory Society
publishDate 2023
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032589/
http://www.ncbi.nlm.nih.gov/pubmed/36889787
https://doi.org/10.1183/16000617.0229-2022
genre First Nations
genre_facet First Nations
op_source Eur Respir Rev
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032589/
http://www.ncbi.nlm.nih.gov/pubmed/36889787
http://dx.doi.org/10.1183/16000617.0229-2022
op_rights Copyright ©The authors 2023
https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
op_doi https://doi.org/10.1183/16000617.0229-2022
container_title European Respiratory Review
container_volume 32
container_issue 167
container_start_page 220229
_version_ 1766002524991520768